Compare DPZ & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DPZ | NBIX |
|---|---|---|
| Founded | 1960 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.2B |
| IPO Year | 2004 | 1996 |
| Metric | DPZ | NBIX |
|---|---|---|
| Price | $371.78 | $132.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 22 |
| Target Price | ★ $469.50 | $180.82 |
| AVG Volume (30 Days) | 828.5K | ★ 950.3K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.89% | N/A |
| EPS Growth | 5.27 | ★ 41.95 |
| EPS | ★ 17.57 | 4.67 |
| Revenue | ★ $4,939,994,000.00 | $161,626,000.00 |
| Revenue This Year | $7.98 | $22.85 |
| Revenue Next Year | $3.97 | $10.36 |
| P/E Ratio | ★ $20.93 | $27.47 |
| Revenue Growth | 4.96 | ★ 977.51 |
| 52 Week Low | $346.31 | $98.95 |
| 52 Week High | $499.08 | $160.18 |
| Indicator | DPZ | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.16 | 54.14 |
| Support Level | $370.70 | $124.29 |
| Resistance Level | $382.13 | $136.23 |
| Average True Range (ATR) | 9.31 | 4.21 |
| MACD | 1.59 | 0.12 |
| Stochastic Oscillator | 71.08 | 85.22 |
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.